GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Debt-to-Equity

SOFIVA GENOMICS Co (ROCO:6615) Debt-to-Equity : 0.08 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Debt-to-Equity?

SOFIVA GENOMICS Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$16.4 Mil. SOFIVA GENOMICS Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$37.0 Mil. SOFIVA GENOMICS Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$644.0 Mil. SOFIVA GENOMICS Co's debt to equity for the quarter that ended in Dec. 2024 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for SOFIVA GENOMICS Co's Debt-to-Equity or its related term are showing as below:

ROCO:6615' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04   Med: 0.11   Max: 0.35
Current: 0.08

During the past 12 years, the highest Debt-to-Equity Ratio of SOFIVA GENOMICS Co was 0.35. The lowest was 0.04. And the median was 0.11.

ROCO:6615's Debt-to-Equity is ranked better than
76.96% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs ROCO:6615: 0.08

SOFIVA GENOMICS Co Debt-to-Equity Historical Data

The historical data trend for SOFIVA GENOMICS Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Debt-to-Equity Chart

SOFIVA GENOMICS Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.14 0.12 0.10 0.08

SOFIVA GENOMICS Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.09 0.09 0.08

Competitive Comparison of SOFIVA GENOMICS Co's Debt-to-Equity

For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOFIVA GENOMICS Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where SOFIVA GENOMICS Co's Debt-to-Equity falls into.


;
;

SOFIVA GENOMICS Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

SOFIVA GENOMICS Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

SOFIVA GENOMICS Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SOFIVA GENOMICS Co  (ROCO:6615) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


SOFIVA GENOMICS Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SOFIVA GENOMICS Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66-1, Sec. 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, pre-natal and neonatal genetic testing and medical testing and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines